Marpai, Inc. · OTC:MRAI
Marpai — IPO Roadshow (October 2023)
23 slides from Marpai's IPO roadshow presentation, Oct 6, 2023
Slide 1: Company Presentation
MARPAI Proprietary and Confidential. © Marpai, Inc. 2023 | MarpaiHealth.com (NASDAQ: MRAI) Company Presentation Filed pursuant to Rule 433 Issuer Free Writing Prospectus Dated October 6, 2023 Relating to Preliminary Prospectus filed October 6, 2023 Registration No. 333-274162 | October 2023
Slide 2: Free Writing Prospectus
Free Writing Prospectus Marpai Inc. This presentation highlights basic information about us and the proposed offering. Because it is a summary, it does not contain all of the information you should consider before investing. Marpai, Inc., (“we”, “us”, “our” or the “Company”) has filed a registration
Slide 3: Forward Looking Statements
3 Forward Looking Statements This presentation and the statements of representatives and partners of Marpai, Inc. (the “Company”) related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securi
Slide 4: Company Overview
Company Overview PROFIT LEVERS WHAT WE DO WHY US REVENUE We save employers money by creating healthier employee population (NASDAQ: MRAI) Manage healthcare spend for employers Employee lives we manage $/employee life Integration & consolidation, into one company Already $12.6M cut on annualized basi
Slide 5: We Predict and Help Modify Risk in Healthcare
We Predict and Help Modify Risk in Healthcare Risk = Cost Health Outcomes Costs 1-3 Comorbidities Time Proprietary and Confidential. © Marpai, Inc. 2023 5
Slide 6: Our Value Proposition
Proprietary and Confidential. © Marpai, Inc. 2023 Our Value Proposition:Healthier employees Lower costs for employers Delivered by:A new way to manage employers’ health plans Building the Health Plan of the Future Health Outcomes Costs| 6
Slide 7: The Ultimate Health Plan for Employers
Proprietary and Confidential. © Marpai, Inc. 2023 1 Company analysis of network discounts against billed charges 56%1 SAVINGS ON BILLED 48%1 SAVINGS ON BILLED Proven clinical solutions. Fees are billed as claims and only when a member participates The Ultimate Health Plan for Employers 2.43M Claims
Slide 8: Full Solution Set for Employers
Proprietary and Confidential. © Marpai, Inc. 2023 RISK PRODUCTS Analytics and insurance Health Plan Administration MARPAI CARES AI-powered predictions and matching of members with proactive care CARE MANAGEMENT Nurses and clinical programs for high-risk members MARPAI CONNECT Ecosystem of value-base
Slide 9: Marpai Connect
Proprietary and Confidential. © Marpai, Inc. 2022 NEW Product Marpai Connect is a value-based care network of digital health providers who put fees at risk to achieve health and cost savings outcomes| 9
Slide 10: How It Works
Proprietary and Confidential. © Marpai, Inc. 2023 Identify Affected & At-Risk Members Clinically Match Proactively Engage Member Enrolls Value-Based Care Plan Impact Claims &Other Data High PotentialAt-Risk Members Value-Based Care Network Provider Outcomes Costs Drives enrollment Marpai nurtures me
Slide 11: New Product for Growth – Small Business Product
Proprietary and Confidential. © Marpai, Inc. 2023 NEW Product for Growth – Small Business Product 1 Kaiser Family Foundation Employer Health Benefits Annual Survey 2022 Small businesses (<200 employees) are rapidly adopting self-insured plans In July 2023, we launched Marpai Vitality, or self-insure
Slide 12: How We Sell
Proprietary and Confidential. © Marpai, Inc. 2023 How We Sell Partnered with leading health plans for companies with <200 employees Broker Channel Small Business Strategy Our focused sales teams works with the largest brokers in America and strong regional brokers Select Broker Partners include: Loc
Slide 13: Financial Section
MARPAI il Financial Section | 13 Proprietary and Confidential. © Marpai, Inc. 2023
Slide 14: 2022, Q2 2023 and Annualized Breakeven Metrics
Proprietary and Confidential. © Marpai, Inc. 20232022 Q2 2023 Annualized Breakeven Employee Lives123,91639,000 55,000 Per Employee Per Month (PEPM)$372$48 $57 GAAP Revenue$24.3 $40.0 $58.0 Revenue Ex. Passthroughs3$11.8$23.6 $37.6 Net Income ($26.5)($30.4)($4.5) Adj. EBITDA($20.0)($22.0)4$0.0 1 Empl
Slide 15: Status of Integration
Proprietary and Confidential. © Marpai, Inc. 2023 Status of Integration One Company, One Team Plan of integration is complete1 Rapid Expense Reduction Reduced $12.6 million in costs, on an annualized basis, in the last year2 Effects of cross-selling to be seen in 2024 (as health plans renew) 1 Purch
Slide 16: Rapid Expense Reduction
Proprietary and Confidential. © Marpai, Inc. 2023 Annualized operating expenses, driven by payroll, reduced by $12.6 million1 Unused facilities have been closed, and we are actively looking to sub-lease them IT consolidation continuing to yield much savings Rapid Expense Reduction Q42022 Q22023 -$7.
Slide 17: Financial Model – Drivers of Growth
Proprietary and Confidential. © Marpai, Inc. 2023 Financial Model – Drivers of Growth 1 Based on YTD September 2022 financials, prior to the acquisition of Maestro Health Q2 2023 Breakeven $36 (78%) $10 (22%) $46 $36 (62%) $5 (9%) $57 $16 (29%) PEPM Components ($) 2 Health Plan Administration: Core
Slide 18: Upside Beyond Our Own Managed Employee Lives
Proprietary and Confidential. © Marpai, Inc. 2023 We launched Marpai Connect and Marpai Rx to our current base of employees to prove out these two products Blue ocean opportunity to sell to other healthcare payers Upside Beyond Our Own Managed Employee Lives 1 Specialty Rx is approximately 20% (cons
Slide 19: Marpai Health Share Structure
Proprietary and Confidential. © Marpai, Inc. 2023Marpai Health (NASDAQ: MRAI) Common Shares Outstanding 7,689,178 Warrants ($20.26 Weighted Average Exercise Price) 504,719 Options ($4.27 Weighted Average Exercise Price)1,418,489 Restricted Stock Units2,023 Fully Diluted Shares9,614,409
Slide 20: Reconciliation of Adjusted EBITDA
Proprietary and Confidential. © Marpai, Inc. 2023 Reconciliation of Adjusted EBITDA High Growth 12 Months Ended December 31, 2022 3 Months Ended December 31, 2022 3 Months Ended March 31, 2023 3 Months Ended June 30, 2023 $ (in thousands) $ (in thousands) $ (in thousands) $ (in thousands) Net Loss (
Slide 21: Seasoned Leadership Team
Proprietary and Confidential. © Marpai, Inc. 2023 Seasoned Leadership Team Edmundo Gonzalez CEO Yoram Bibring CFO Yaron Eitan Chairman Damien LamendolaDirector Mohsen Moazami Director Colleen DiClaudioDirector Vincent Kane Director Yaron Eitan Chairman Edmundo Gonzalez CEO Seasoned Leadership Team B
Slide 22: Investment Summary
Proprietary and Confidential. © Marpai, Inc. 2023 Organic + Acquisitions + Other Payers + Tech-Driven Disruption Expanding # of Lives Covered Investment Summary High Growth Health Outcomes Costs| 22
Slide 23: Thank you
WHAT WILL BE Thank you